IQVIA Holdings Inc. Profile Avatar - Palmy Investing

IQVIA Holdings Inc.

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solution…
Medical - Diagnostics & Research
US, Durham [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 0% Bad
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 1.66 0.88 0.86
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 6.21 15.60 14.69
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.80 34.88 33.60
Cash 5.28 8.66 8.22
Capex 18.99 -0.80 -0.98
Free Cash Flow -33.63 2.07 3.12
Revenue -4.32 20.56 21.49
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -3.26 0.28 0.29
Operating Margin -2.03 0.14 0.14
ROA -38.35 0.01 0.02
ROE -40.84 0.05 0.08
ROIC -36.96 0.02 0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of IQV is permitted for members.
5 Growth
The "Growth Entry" for the Focus of IQV is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of IQV is permitted for members.
End of IQV's Analysis
CIK: 1478242 CUSIP: 46266C105 ISIN: US46266C1053 LEI: - UEI: -
Secondary Listings